


期刊介绍
Ophthalmic Genetics accepts original papers, review articles and short communications on the clinical and molecular genetic aspects of ocular diseases. The journal invites several types of contributions divided into sections:
Editorial - By invitation. To be written by the Editor-in-Chief or any other member of the editorial board. Preferably deals with articles in the same issue, but may deal with unrelated subjects of importance to the readership.
Reviews and perspectives - Invited and uninvited reviews in ophthalmic genetics or related topics. May include synopsis of current literature on a specific topic.
Research reports - Original research material on the clinical and molecular genetic aspects of the ocular disorders.
Expedited articles - Reserved for molecular genetic studies needing prompt publication to set record of discovery.
Short communications/Case reports - Articles dealing with single cases. No limitations on size of manuscripts.
Mutation Reports - Andreas Gal, Hamburg Germany
Current Literature - Abstracts of articles from current literature, carefully selected and prepared by the section editor Dr. Robert Koenekoop
Letters to the Editor - Correspondence submitted to the editors by the readers and pertaining to published articles. Includes replies of authors.
Book Review
Calendar of events
眼科遗传学接受有关眼科疾病的临床和分子遗传学方面的原始论文、评论文章和简短交流。《华尔街日报》邀请了几类分为几部分的投稿:
受邀发表社论。由主编或编委会其他成员撰写。最好处理同一问题的文章,但可能处理与读者重要的无关主题。
评论和观点-眼科遗传学或相关主题的邀请和不邀请评论。可能包括特定主题的当前文献概要。
研究报告-眼科疾病临床和分子遗传学方面的原始研究材料。
加急文章-为分子遗传学研究保留,需要立即发表以记录发现。
简短的沟通/案例报告-处理单个案例的文章。手稿的大小没有限制。
突变报告-Andreas Gal,德国汉堡
当前文献-当前文献的文章摘要,由部门编辑Robert Koenekoop博士精心挑选和准备
致编辑的信件-读者提交给编辑的与已发表文章有关的信件。包括作者的回复。
书评
活动日历。全名/缩写 | OPHTHALMIC GENET/OPHTHALMIC GENETICS |
期刊ISSN | 1381-6810 |
2022-2023影响因子 | 1.200 实时影响因子查询 (由greensci.net提供-2019 New!) |
最新自引率 | 9.80 |
期刊官方网站 | http://informahealthcare.com/loi/opg |
是否OA开放访问 | No |
出版国家或地区 | UNITED STATES |
出版年份 | 1994 |
中科院JCR分区 | 大类:4区小类:4区 |
SCI期刊coverage | Science Citation Index Expanded |
审稿速度(网友添加,非官方) | >12周,或约稿 |
×
绿色通道审稿 加急发表
可添加微信号:meibisi123